Skip to main navigation Skip to search Skip to main content

Keratoacanthoma-like eruption associated with pembrolizumab and dupilumab treated by intralesional triamcinolone: A case report

  • Raphaella Lambert
  • , Elizabeth Rotrosen
  • , Hannah Verma
  • , Grace Rabinowitz
  • , Patricia Heller
  • , Nicholas Gulati

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalJAAD Case Reports
Volume61
DOIs
StatePublished - Jul 2025

Keywords

  • cutaneous immune-related adverse event
  • dupilumab
  • immunotherapy
  • keratoacanthoma
  • lichenoid
  • pembrolizumab

Cite this